Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl.
A prospective study of 500 consecutive persons (aged 60 years with Q-wave myocardial infarction admitted to a long-term health care facility) investigated the prevalence of the use of a lipid-lowering drug at the time of admission in persons with a fasting serum low-density lipoprotein (LDL) cholesterol >125 mg/dl measured the day after admission. The prevalence of a lipid-lowering drug in persons with myocardial infarction and an LDL cholesterol >125 mg/dl was 7% (11 of 153 persons) in persons 60 to 80 years of age and 3% (6 of 182 persons) in persons 81 to 100 years of age.
Aronow
W S
WS
Hebrew Hospital Home, Bronx, New York 10475, USA.
D000368:Aged; D000369:Aged, 80 and over; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood*; D003431:Cross-Cultural Comparison; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D011446:Prospective Studies; D012537:Scandinavian and Nordic Countries; D019821:Simvastatin / Q000627:therapeutic use*; D015996:Survival Rate; D014481:United States
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D019821:Simvastatin